Summary
Mount Sinai, Israel's Sheba Medical Center, and NVIDIA have teamed up to use artificial intelligence (AI) to study the human genome. They aim to discover new ways to prevent, diagnose, and treat diseases with this research. The collaboration plans to leverage AI technology to analyze genomic data and uncover patterns linked to health issues.
Key Facts
- Mount Sinai, Sheba Medical Center, and NVIDIA will work together for three years.
- They are using an AI tool called a large language model to study the human genome.
- The project seeks to find new pathways for disease prevention and treatment.
- The research will look into parts of the genome once considered "junk DNA" for important genetic functions.
- Sheba and Mount Sinai will provide genome data and research expertise, while NVIDIA will supply AI technology and support.
- The initiative is part of Mount Sinai's Million Health Discoveries Program.
- NVIDIA's AI platform will help create a Genomic Foundation Model (gFM) to uncover genetic information related to health risks.
- The collaboration combines global resources to push forward medical research and improve healthcare worldwide.
